Tillkännagivande • Jun 13
Halma plc Announces Board Changes, Effective 23 July 2026 Halma plc announced that Jo Harlow would step down as a Director of the Company at the conclusion of the Annual General Meeting to be held on July 23, 2026. The following changes to Board and Committee responsibilities would take effect at the conclusion of the Annual General Meeting: Sharmila Nebhrajani OBE would be appointed as Senior Independent Director; and Giles Kerr would be appointed as Chair of the Remuneration Committee. Tillkännagivande • Jun 12
Halma plc Announces Departure of Catherine Miche as Chief Technology Officer At the End of June Halma plc announced after seven years with Halma, Catherine Miche, Chief Technology Officer, will leave at the end of June. Over the past seven years, Catherine has established a technology function that has supported group-wide transformation, including digitalisation and Al adoption across the companies. Tillkännagivande • May 29
Halma plc Announces Management Changes Halma PLC announced that Constance Baroudel, Environmental & Analysis Sector Chief Executive, would leave Halma at the end of August 2026 to become Chief Executive of Spectris Ltd. Steve Brown, currently Healthcare Sector Chief Executive, would succeed Constance Baroudel as Environmental & Analysis Sector Chief Executive from September 1, 2026. As part of this succession, Bill Stoval, currently a Healthcare Sector Divisional Chief Executive, would be promoted to Healthcare Sector Chief Executive and become a member of the Executive Board. Steve Brown was appointed to the Executive Board in November 2021. He is an experienced Halma leader, having driven success in the business for more than ten years across different roles in all three sectors. Steve has a strong track record of building high-performing teams and delivering organic and acquisition growth. Prior to his appointment as Healthcare Sector Chief Executive, Steve was Divisional Chief Executive of Halma's Environmental & Analysis Sector, Divisional Chief Executive for the Safety Sector and Managing Director of Apollo, one of Halma's largest companies. Steve joined Halma in 2015 from US global industrial company ITW. He holds a Masters in Engineering from the University of Cambridge. Bill Stoval is a Divisional Chief Executive in Halma's Healthcare Sector. In his role, Bill chairs the boards of several of Halma's healthcare companies and is responsible for delivering both organic growth and acquisitions. He joined Halma in 2019 following a career spanning over twenty years in the healthcare and technology sectors, including senior roles at major global companies including GE Healthcare and IBM Watson Health where he built and led businesses. Bill brings strong leadership, strategic, operational and entrepreneurial skills and has delivered an impressive track record of organic and acquisition growth at Halma. He holds a Computer Engineering degree from the University of Notre Dame and a Masters in Electrical Engineering from Marquette University, as well as an MBA from the Kellogg School of Management at Northwestern University. Tillkännagivande • Jan 10
Halma plc (LSE:HLMA) acquired Safetec Srl for €72.5 million. Halma plc (LSE:HLMA) acquired Safetec Srl for €72.5 million on January 9, 2026. The cash consideration for Safetec is €72.5 million, on a cash- and debt-free basis, to be funded from Halma's existing facilities.
Safetec will be a standalone company within Halma's Safety Sector, led by its current management team.
Halma plc (LSE:HLMA) completed the acquisition of Safetec Srl on January 9, 2026. Tillkännagivande • Dec 06
Halma plc (LSE:HLMA) acquired European Safety Systems Limited for £230 million. Halma plc (LSE:HLMA) acquired European Safety Systems Limited for £230 million on December 5, 2025. A cash consideration of £230 million will be paid by Halma plc. As part of consideration, £230 million is paid towards common equity of European Safety Systems Limited. The cash consideration for E2S is £230 million, on a cash- and debt-free basis, to be funded from Halma's existing facilities.
Halma plc (LSE:HLMA) completed the acquisition of European Safety Systems Limited on December 5, 2025. Tillkännagivande • Nov 29
Halma plc to Report Q2, 2027 Results on Nov 19, 2026 Halma plc announced that they will report Q2, 2027 results at 8:00 AM, GMT Standard Time on Nov 19, 2026 Tillkännagivande • Sep 25
Halma plc to Report First Half, 2026 Results on Nov 20, 2025 Halma plc announced that they will report first half, 2026 results on Nov 20, 2025 Tillkännagivande • Sep 05
Halma plc to Report Fiscal Year 2026 Results on Jun 11, 2026 Halma plc announced that they will report fiscal year 2026 results on Jun 11, 2026 Tillkännagivande • Aug 27
Halma plc (LSE:HLMA) acquired Brownline BV from Mentha Capital B.V. and others for €150 million. Halma plc (LSE:HLMA) acquired Brownline BV from Mentha Capital B.V. for €150 million on August 26, 2025. The cash consideration for Brownline is €150 million, on a cash- and debt-free basis, to be funded from Halma's existing facilities. Brownline will be a standalone company within Halma's Environmental & Analysis Sector, led by its current management team.
Brownline's unaudited revenue for the 12 months to 31 March 2025 was €37 million.
Martijn Koops, Sibert Meulenbelt, Carlo de Haas and Wouter Abrahams of Lincoln International acted as financial advisor for the shareholders of Brownline BV.
Halma plc (LSE:HLMA) completed the acquisition of Brownline BV from Mentha Capital B.V. and others on August 26, 2025. Tillkännagivande • Jul 28
Saothair Capital Partners, LLC acquired Air Products And Controls, Inc. from Halma plc (LSE:HLMA). Saothair Capital Partners, LLC acquired Air Products And Controls, Inc. from Halma plc (LSE:HLMA) on July 28, 2025. Following the transaction, AAI will be named Air Products and Controls Inc. McGuireWoods LLP provided legal counsel to Saothair on the transaction. Halma was represented by Nixon Peabody LLP for legal counsel and Houlihan Lokey as financial advisor.
Saothair Capital Partners, LLC completed the acquisition of Air Products And Controls, Inc. from Halma plc (LSE:HLMA) on July 28, 2025. Tillkännagivande • Jun 23
Halma plc to Report Fiscal Year 2026 Results on Mar 31, 2026 Halma plc announced that they will report fiscal year 2026 results on Mar 31, 2026 Tillkännagivande • Jun 12
Halma plc, Annual General Meeting, Jul 24, 2025 Halma plc, Annual General Meeting, Jul 24, 2025. Tillkännagivande • Mar 21
Halma Announces the Appointment of Barbara Thoralfsson as an Independent Non-Executive Director, Effective 16 June 2025 Halma announced the appointment of Barbara Thoralfsson as an independent non-executive Director, with effect from 16 June 2025. Barbara will also be a member of Halma's Audit, Remuneration and Nomination Committees. Barbara brings extensive international experience from her executive and non-executive positions in public and private companiesacross numerous sectors, including industrial, telecommunications and technology. She is entrepreneurial and deeply passionate about sustainability, having founded Fleming Industrier AS, owner of the largest recycler of plastic waste in the Nordics.Barbara is non-executive Chair at Exclusive Networks SA, where she is leading the sale to a private equity consortium, and previously served as an Industrial Advisor to EQT Private Equity Partners. Following her early careerwithin the FMCG industry in the USA and Scandinavia, Barbara moved into the telecommunications industry, where she served as CEO of NETCOM ASA, Norway's second largest mobile network operator at that time. Her non-executive career spans 20 years and includedTandberg ASA, a leading global supplier of video conferencing systems, Telenor ASA, a leading mobile operator in Scandinavia, Eastern Europe and Asia, Electrolux AB, Cable & Wireless Plc and Colart International Holdings (latterly as Chair). Barbara served as a non-executive director at security services group, G4S plc which was a constituent of the FTSE 250. Barbara serves as a non-executive director on the boards of SCA AB, Hilti AG and Essity AB. She is a member of the Advisory Council for SB1 Markets. Tillkännagivande • Mar 13
Halma plc Reaffirms Earnings Guidance for the Full Year to March 2025 Halma plc reaffirmed earnings guidance for the full year to March 2025. Halma plc's guidance for good organic constant currency revenue growth for the full year to March 2025 is unchanged from that given in half year results announcement. Tillkännagivande • Nov 18
Halma plc (LSE:HLMA) acquired Lamidey Noury Medical for €50 million. Halma plc (LSE:HLMA) acquired Lamidey Noury Medical for €50 million on November 18, 2024. A cash consideration of €50 million will be paid by Halma plc. As part of consideration, €50 million is paid towards common equity of Lamidey Noury Medical. The cash consideration for Lamidey Noury is €50m, on a cash- and debt-free basis, to be funded from Halma's existing facilities. For the period ending October 31, 2024, Lamidey Noury Medical reported total revenue of €13.6 million. As part of the transaction, Lamidey Noury will be a standalone company within Halma's Healthcare Sector, led by its current management team.
Halma plc (LSE:HLMA) completed the acquisition of Lamidey Noury Medical for €50 million on November 18, 2024 Tillkännagivande • Sep 26
Halma plc Provides Group Revenue Guidance for the First Half of Ending September 30, 2024 and Full Year Ending March 2025 Halma plc provided group revenue guidance for the first half of ending September 30, 2024 and full year ending March 2025. In the first half of the year, the company expects to deliver good organic constant currency revenue growth, supported by Group order intake in the year to date which is ahead of both revenue and the comparable period last year.
For the full year to March 2025, the company expects good organic constant currency revenue growth. Tillkännagivande • Jun 26
Groupe CLAIRE SAS entered into an agreement to acquire HYDREKA SAS from Halma plc (LSE:HLMA) for €8.4 million. Groupe CLAIRE SAS entered into an agreement to acquire HYDREKA SAS from Halma plc (LSE:HLMA) for €8.4 million on May 31, 2024. A cash consideration of €8.4 million will be paid by Groupe CLAIRE SAS. As part of consideration, €8.4 million is paid towards common equity of HYDREKA SAS. For the period ending December 31, 2023, HYDREKA SAS reported total revenue of €9 million. Philippe Schmitt, Alan Granberg and Cory Kenny of EuroConsult Capital, LLC acted as financial advisor for Halma plc. Tillkännagivande • Jun 15
Halma plc, Annual General Meeting, Jul 25, 2024 Halma plc, Annual General Meeting, Jul 25, 2024. Tillkännagivande • Jun 14
Halma plc Recommends Final Dividend for the Financial Year Ended March 31, 2024, Payable on 16 August 2024 Halma plc announced is recommending a 7% increase in the final dividend to 13.20 pence per share (2023: 12.34 pence per share). If approved at Annual General Meeting, together with the 8.41 pence per share interim dividend, this would result in a total dividend for the year of 21.61 pence (2023: 20.20p), also up 7%, making this the 45th consecutive year of dividend per share growth of 5% or more. The final dividend for the financial year ended March 31, 2024 is subject to approval by shareholders at the Annual General Meeting on 25 July 2024 and, if approved, will be paid on 16 August 2024 to shareholders on the register at 12 July 2024. Tillkännagivande • Mar 04
Halma plc (LSE:HLMA) acquired Rovers Medical Devices B.V. Halma plc (LSE:HLMA) acquired Rovers Medical Devices B.V. for €91 million on March 4, 2024. The initial consideration for Rovers is €85 million on a cash- and debt-free basis, which will be paid in cash and funded from Halma's existing facilities. An additional consideration of up to €6 million is payable in cash, based on Rovers' performance in the period to March 31, 2025. Rovers will be a standalone company within Halma's Healthcare sector, led by its current management team. Rovers Medical Devices has reported revenue of €12 million on December 31, 2023. Oliver Hughes, Rachel Farrington and Ollie Hoare of MHP has worked in this transaction.
Halma plc (LSE:HLMA) completed the acquisition of Rovers Medical Devices B.V. on March 4, 2024. Tillkännagivande • Jan 30
Halma plc Announces Executive Changes, Effective February 1, 2024; June 7, 2024 Halma plc announced the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma's Audit, Remuneration and Nomination Committees. Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023. His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc. Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024. Tillkännagivande • Nov 22
Halma plc (LSE:HLMA) acquired TeDan Surgical Innovations, Inc. for $100 Million. Halma plc (LSE:HLMA) acquired TeDan Surgical Innovations, Inc. for $100 Million on November 20, 2023. The initial cash consideration for TeDan is US$89.1m (approximately £72m), on a cash- and debt-free basis. An additional earn-out consideration of up to US$10.9m (approximately £9m) is payable in cash, based on TeDan's performance in the period to June 2024. The initial cash consideration will be funded from Halma's existing facilities. TeDan's consolidated unaudited revenue for the 12 months to 31 March 2023 was US$29.2m (approximately £24m). TeDan will be a standalone company in Halma's Healthcare sector, led by its current management team. TeDan team joins Halma.Halma plc (LSE:HLMA) completed the acquisition of TeDan Surgical Innovations, Inc. on November 20, 2023. Tillkännagivande • Sep 21
Halma plc Provides Revenue Guidance for the Full Year Ending March 2024 Halma plc provided revenue guidance for the full year to March 2024, for good organic constant currency revenue growth and Return on Sales of approximately 20%, is unchanged from that given in results announcement in June. Accordingly, in the first half of the year, the company expects good organic constant currency revenue growth against a strong comparative period last year, and Return on Sales towards the lower end of the target range. Tillkännagivande • Aug 05
Halma plc (LSE:HLMA) acquired Lazer Safe Pty Ltd for AUD 45 million. Halma plc (LSE:HLMA) acquired Lazer Safe Pty Ltd for AUD 45 million on August 4, 2023. Lazer Safe revenue for the 12 months to 31 March 2023 was AUD 21.8 million.Halma plc (LSE:HLMA) completed the acquisition of Lazer Safe Pty Ltd on August 4, 2023. Tillkännagivande • Jul 25
Halma plc Announces Directorate Change Halma plc announces the following changes: Appointment of independent non-executive Director: Liam Condon will be appointed as an independent non-executive Director, with effect from 25 September 2023. Liam will also be a member of Halma's Audit, Remuneration and Nomination Committees. Liam brings a wealth of experience gained across a variety of roles, with a strong global background in driving growth and sustainability in the Life Science, Chemical and Energy Transition Industries. He is currently Chief Executive of Johnson Matthey plc and earlier in his career, Liam held senior positions within Bayer AG and Schering AG. Tony Rice has informed the Company that, having served for nearly nine years as a non-executive Director, he will step down from the role of Senior Independent Director on 31 July 2023 and retire as a non-executive Director on 31 December 2023. As part of the Company's succession plans, and following the unanimous support of the Board, Jo Harlow will be appointed as Senior Independent Director with effect from 1 August 2023. Tillkännagivande • May 13
Halma plc (LSE:HLMA) acquired Sewertronics Sp. Z O.o. Halma plc (LSE:HLMA) entered into an agreement to acquire Sewertronics Sp. Z O.o. for €59 million on May 5, 2023. The initial cash consideration for Sewertronics is to be funded from Halma's existing facilities and Additional considerations of up to €18 million will be payable in cash, based on the fulfilment of certain conditions. The Completion of the acquisition is subject to certain closing conditions. Sewertronics will be a standalone company within Halma's Environmental & Analysis sector, and will collaborate with Minicam and Dancutter, existing Halma portfolio companies, who operate in the same end-user markets. Sewertronics' unaudited revenue for the 12 months ended on 31 December 2022 was €8.1 million. The closing of transaction is expected to occur by the end of May 2023.Halma plc (LSE:HLMA) completed the acquisition of Sewertronics Sp. Z O.o. on May 12, 2023. Tillkännagivande • May 06
Halma plc (LSE:HLMA) entered into an agreement to acquire Sewertronics Sp. Z O.o. for €59 million Halma plc (LSE:HLMA) entered into an agreement to acquire Sewertronics Sp. Z O.o. for €59 million on May 5, 2023. The initial cash consideration for Sewertronics is to be funded from Halma's existing facilities and Additional considerations of up to €18 million will be payable in cash, based on the fulfilment of certain conditions. The Completion of the acquisition is subject to certain closing conditions. Sewertronics will be a standalone company within Halma's Environmental & Analysis sector, and will collaborate with Minicam and Dancutter, existing Halma portfolio companies, who operate in the same end-user markets. Sewertronics' unaudited revenue for the 12 months ended on 31 December 2022 was €8.1 million. The closing of transaction is expected to occur by the end of May 2023. 
